Patents by Inventor Todd Andrew Blumenkopf

Todd Andrew Blumenkopf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding mutant human carboxypeptidase A enzymes
    Patent number: 6319702
    Abstract: The present invention relates to nucleic acid molecules encoding mutant human carboxypeptidase A enzymes, and encoding conjugates of targeting molecules and mutant human carboxypeptidase A enzymes. The invention further relates to vectors and cell lines containing such nucleic acid molecules.
    Type: Grant
    Filed: September 14, 1999
    Date of Patent: November 20, 2001
    Assignee: Glaxo Wellcome, Inc.
    Inventors: Gary Keith Smith, Todd Andrew Blumenkopf, Michael Cory
  • Cell-targeting molecule comprising a mutant human carboxypeptidase A
    Patent number: 6140100
    Abstract: Conjugates of a cell targetting molecule and a mutant human carboxypeptidase A enzyme are provided. Suitable targetting molecules include antibodies, hormones, ligands, cytokines, antigens, oligonucleotides and peptidomimetics. Enzymes comprising a mutant human carboxypeptidase A enzyme are also provided.
    Type: Grant
    Filed: May 9, 1996
    Date of Patent: October 31, 2000
    Assignee: Glaxo Wellcome Inc.
    Inventors: Gary Keith Smith, Todd Andrew Blumenkopf, Michael Cory